Search

Your search keyword '"Le Masson, Gwendal"' showing total 59 results

Search Constraints

Start Over You searched for: Author "Le Masson, Gwendal" Remove constraint Author: "Le Masson, Gwendal" Database MEDLINE Remove constraint Database: MEDLINE
59 results on '"Le Masson, Gwendal"'

Search Results

1. Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial.

3. The various forms of hereditary motor neuron disorders and their historical descriptions.

4. Clinical Neurology in Practice: The Tongue (part 2).

5. Clinical Neurology in Practice: The Tongue (Part 1).

6. At-home noninvasive ventilation initiation with telemonitoring in amyotrophic lateral sclerosis patients: a retrospective study.

7. Usefulness of subcutaneous immunoglobulin therapy in the management of myasthenia gravis: a retrospective cohort study.

8. Acute peripheral neuropathy following animal envenomation: A case report and systematic review.

9. The European Lambert-Eaton Myasthenic Syndrome Registry: Long-Term Outcomes Following Symptomatic Treatment.

10. Peripheral neuropathy and livedoid vasculopathy.

11. Neurologic manifestations of giant cell arteritis.

12. Myasthenia Gravis Lambert-Eaton overlap syndrome induced by nivolumab in a metastatic melanoma patient.

13. The ataxic neuropathies.

14. Charcot-Marie-Tooth disease misdiagnosed as chronic inflammatory demyelinating polyradiculoneuropathy: An international multicentric retrospective study.

15. Olfaction and anosmia: From ancient times to COVID-19.

16. Effect of familial clustering in the genetic screening of 235 French ALS families.

17. Impact of Coronavirus Disease 2019 in a French Cohort of Myasthenia Gravis.

18. Epidemics and outbreaks of peripheral nervous system disorders: I. infectious and immune-mediated causes.

19. Epidemics and outbreaks of peripheral nervous system disorders: II. Toxic and nutritional causes.

21. History of acute polyradiculoneuropathy (part 1): The prehistory of Guillain-Barré syndrome.

22. History of acute polyradiculoneuropathy (part 2): From 1916 to 2019.

23. Minimizing the Diagnostic Delay in Amyotrophic Lateral Sclerosis: The Role of Nonneurologist Practitioners.

24. Prognostic factor of poor outcome in anti-MAG neuropathy: clinical and electrophysiological analysis of a French Cohort.

25. Theme 4 In vivo experimental models.

26. Papilledema and Peripheral Neuropathies.

27. Early clinicopathologic description of nodoparanodopathy in the 19th century.

28. Myopathy and scleromyxedema.

29. Focal neurogenic muscle hypertrophy and fasciculations in multifocal motor neuropathy.

32. Value of nerve biopsy in the management of peripheral neuropathies.

33. Safety of Intravenous Immunoglobulin (Tegeline®), Administered at Home in Patients with Autoimmune Disease: Results of a French Study.

34. Updating the classification of inherited neuropathies: Results of an international survey.

35. Chronic inflammatory demyelinating polyradiculoneuropathy-causing myelopathy.

36. Home versus hospital immunoglobulin treatment for autoimmune neuropathies: A cost minimization analysis.

37. RNA-Targeted Therapies and Amyotrophic Lateral Sclerosis.

38. History and current difficulties in classifying inherited myopathies and muscular dystrophies.

39. Acute Brachial Radiculoplexopathy and Giant Cell Arteritis.

40. Did Jules Dejerine describe AMAN at the end of the 19th century?

41. Management and therapeutic perspectives in amyotrophic lateral sclerosis.

42. Current view and perspectives in amyotrophic lateral sclerosis.

43. Therapeutic options and management of polyneuropathy associated with anti-MAG antibodies.

44. The European LEMS Registry: Baseline Demographics and Treatment Approaches.

45. A computational model of motor neuron degeneration.

46. Neonatal testosterone suppresses a neuroendocrine pulse generator required for reproduction.

48. State-dependent, bidirectional modulation of neural network activity by endocannabinoids.

49. Neurons are MHC class I-dependent targets for CD8 T cells upon neurotropic viral infection.

50. Multiple firing patterns in deep dorsal horn neurons of the spinal cord: computational analysis of mechanisms and functional implications.

Catalog

Books, media, physical & digital resources